Side-by-side comparison of AI visibility scores, market position, and capabilities
Fresh dog food subscription delivering pre-portioned refrigerated human-grade meals; personalized portion plans for pets competing with Nom Nom and Ollie in premium DTC pet food market.
The Farmer's Dog is a direct-to-consumer fresh pet food subscription company delivering pre-portioned, refrigerated, human-grade dog food (made with fresh meat and vegetables, cooked in USDA-certified facilities) directly to customers' homes on a subscription basis — disrupting the traditional kibble-dominated pet food market with fresh, personalized nutrition. Founded in 2014 by Brett Podolsky and Jonathan Regev in New York City, The Farmer's Dog has raised approximately $150 million and has grown rapidly as the premium pet food category has expanded with pet humanization trends.\n\nThe Farmer's Dog's meal plans are personalized — customers complete a health profile for their dog (breed, age, weight, activity level, any health conditions), and the company formulates a specific daily calorie plan and delivers the appropriate portion sizes. Meals are made with whole-food ingredients (turkey and sweet potato, beef and rice, chicken and lentils) with no artificial preservatives, fillers, or by-products. The subscription model and refrigerated delivery create a high-frequency engagement cadence with customers.\n\nIn 2025, The Farmer's Dog competes in the fresh dog food market alongside Nom Nom (acquired by Mars Petcare), Ollie, PetPlate, and A Pup Above — all competing for the premium pet owner willing to spend $60-200/month on fresh dog food versus $20-60/month on premium kibble. The fresh pet food market has grown significantly but remains a small fraction of the overall $58 billion US pet food market, which is dominated by dry kibble from Mars, Nestlé Purina, and Hill's. The Farmer's Dog's 2025 strategy focuses on growing brand awareness through national advertising (the brand ran a Super Bowl commercial in 2023 that significantly increased awareness), expanding its veterinary relationship for prescription diet products, and expanding internationally.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.